Saúdejulho 24, 2024

How AI software enhances 8 critical monitoring practices for drug diversion

Preventing and identifying drug diversion is challenging without the assistance of advanced technology; traditional methods are often insufficient to detect sophisticated schemes. AI works to address the issue of drug diversion.

As healthcare organizations face increasing pressure to enhance patient safety and regulatory compliance, AI-driven surveillance is emerging as a strategic asset in combating drug diversion. However, only 37.5% of respondents to a recent survey report using AI tools for drug diversion detection.

AI and drug diversion software create a critical monitoring system

Advanced platforms are revolutionizing detection by integrating data. Strategically focus on these eight critical monitoring practices ranging from medication dispensing to infusion pump analytics where drug diversion AI technology can significantly enhance detection and prevention efforts:

1. Monitoring continuous infusion and PCA infusions

Continuous and PCA infusions are high-risk for diversion due to the volume and potency of opioids. Effective monitoring helps ensure that these medications are administered safely and used by the intended patients. It also allows for detecting anomalies, such as discrepancies in medication volumes, unusual administration patterns, or frequent overrides in automated dispensing cabinets. AI software can consolidate information from infusion pumps, documentation in flowsheets, and MAR records to identify discrepancies alleviating the labor-intensive processes required to monitor manually.

2. Monitoring anesthesia alerts for start and end procedure times

Another essential component of a comprehensive drug diversion program is monitoring anesthesia alerts for start and end procedure times. By closely tracking the start and end times of procedures, we can correlate the administration of medications highly susceptible to diversion with the documented duration of anesthesia, ensuring that all administered drugs align correctly with patient care activities. Discrepancies may signal diversion. For example, if a significant amount of a controlled substance is documented as used outside of the scheduled procedure times or someone not credentialed accesses the drugs, it raises a red flag for potential diversion.

3. Corresponding orders for medication administration

Administering medication without an order is a key diversion risk. The absence of an order means there is no official record or clinical justification for the medication's use, creating an opportunity for individuals to exploit this gap for unauthorized purposes. Medication overrides are a critical dispensing practice to review and audit. AI can trend data from medication overrides to identify users who may be exploiting this gap to divert medications. Strict protocol adherence helps prevent diversion and ensures compliance.

4. Drug diversion AI technology alerts tailored to healthcare workers' workflows

Tailoring diversion alerts to each healthcare worker's role improves detection and prevents medication misuse.

  • Nurse's workflow involves administering medications directly to patients, often during high-stress and fast-paced shifts. Drug diversion technology for nurses should focus on timely, point-of-care alerts that warn of potential discrepancies quickly. This allows for swift corrective actions and minimizes the risk of errors or intentional diversion.
  • Pharmacists and pharmacy technicians manage medication preparation, dispensing, and inventory control. Their workflows often include detailed documentation and inventory management tasks, so diversion alerts for these roles should emphasize tracking inventory discrepancies or frequent overrides of standard procedures. By flagging these specific activities, the technology can help identify and address potential diversion at the point of medication handling.
  • Anesthesia workflow often involves administering controlled substances without explicit physician orders to various patients in differing surgical procedures. Drug diversion alerts in this area can track the amount of controlled substances administered per procedure, detect anomalous usage patterns, and ensure that documented amounts of administrations and wastes match dispensed amounts.
SOLUTIONS
Sentri7® Drug Diversion
Quickly uncover potential diversion from purchase to patient with predictive analytics and actionable dashboards.
Reconciles drug transactions using AI to rapidly and accurately identify patterns of behavior consistent with drug diversion.

5. Tracking controlled and non-controlled substances for suspected drug diversion

Controlled substances require strict tracking due to their high potential for abuse. Despite these measures, the challenge remains in ensuring timely accuracy across different departments and shifts. Diversion often occurs in subtle ways, such as falsifying records or manipulating medication counts, making it difficult to detect discrepancies without robust monitoring systems. In addition, non-controlled substances often get overlooked due to the lack of regulatory oversight. Therefore, it is imperative not to exclude them from rigorous oversight and documentation practices. The lack of tracking can create opportunities for drug diversion that go unnoticed until significant discrepancies arise.

Managing this large medication inventory adds complexity. Each type of medication requires specific handling, storage, and administration protocols, adding layers to the tracking process. Integration of advanced technology, such as automated dispensing systems and timely analytics, can assist in monitoring both controlled and non-controlled substances.

6. Indications of potential drug diversion through pain scores

Some healthcare workers may over-report pain to justify higher doses, enabling diversion for personal use or illegal distribution. Conversely, unexplained drops in pain scores with no corresponding medical interventions may also raise red flags, indicating potential record manipulation or unauthorized medication administration. A thorough review of pain scores with medication administration records can identify potential diversion patterns.

  • Frequent requests for pain medications, particularly from specific patients or by certain healthcare workers, warrant closer scrutiny.
  • Healthcare workers who frequently omit pain score documentation may not be assessing their patients and falsifying administration information to cover their tracks from diversion.
  • Diversion can also involve subtle manipulation of pain assessment and medication documentation to avoid detection.

Regular audits of pain scores and cross-referencing them with other clinical data, such as patient diagnoses and prescribed treatment plans, enhance the ability to spot discrepancies. By maintaining a vigilant approach to pain score evaluation, healthcare facilities can better protect their medication inventory and ensure patient safety.

7. Comparing contract and float staff in a drug diversion program

Contract and float staff support care continuity, but their transient nature and varied responsibilities can pose unique challenges. A lack of familiarity with the institution's protocols and culture can lead to errors or breaches. They may also have fewer long-term accountability measures. Comparing their activities and access to medications against those of regular employees can help identify any unusual patterns or discrepancies that might suggest diversion.

Implementing advanced tracking technologies and routine audits tailored to the unique workflows of these groups can further strengthen diversion prevention efforts. Regular cross-referencing of medication usage data and adherence to safety protocols can ensure that deviations by contract and float staff are promptly detected and addressed.

8. Clinical surveillance and practice review alerts

Clinical surveillance ensures that potential issues are detected early, allowing for timely intervention and prevention of further incidents. Practice alerts act as a real-time alert for deviations from protocols and best practices. For instance, if a nurse administers a higher-than-expected dose of medication or logs multiple overrides into the dispensing system, an alert can be triggered to prompt immediate investigation. These alerts can be tailored to specific workflows, ensuring that they are relevant and effective.

The integration of clinical surveillance and practice review alerts offers multiple benefits:

  • Ensure deviations are documented and can be traced back to the responsible individual. This accountability acts as a deterrent against diversion, as the likelihood of being caught is significantly increased.
  • Support the early detection of problematic patterns, such as repeated inconsistencies or unusual dispensing practices, which might not be evident through routine audits alone.

Barriers to drug diversion AI technology adoption

Despite the fact that only 37.5% of respondents report using AI tools for drug diversion detection, a majority express a desire to adopt these technologies in the future. It is reported that 65% of U.S. based hospitals use AI-assisted predictive patient care models already. AI adoption in drug diversion detection can be limited by financial and resource constraints, cultural and leadership resistance, and technical integration issues.

Why is the adoption rate for AI in drug diversion programs so low? The biggest holdouts tend to be small to medium-sized hospitals. Despite a desire to invest, the budget constraints especially create a too-high barrier to investment.

AI and drug diversion work together

Using AI technology, like Sentri7 Drug Diversion, to identify and correct best practice issues across your facility allows you to identify diversion more effectively. See how you stack up against your peers and find actionable insights on how to strengthen your drug diversion program in our State of Drug Diversion report 2025.

Learn About Sentri7 Drug Diversion
State Of Drug Diversion Report
Gordon Watkins
Specialized Consulting Manager
Dr. Gordon Watkins has over 8 years of experience in institutional pharmacy clinical practice and operations, most specifically in implementing and optimizing pharmacy technology solutions.
Back To Top